Cite
HARVARD Citation
Rossi, I. et al. (2020). 24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy. Atherosclerosis. pp. e279-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rossi, I. et al. (2020). 24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy. Atherosclerosis. pp. e279-. [Online].